Begin main content

Call for Patient Input and Clinical Experts: esketamine hydrochloride

May 27, 2019
CADTH has received the following notice(s) of pending drug submission(s). Brand name TBC Generic name esketamine hydrochloride Manufacturer Janssen Inc. Indication(s) Major depressive disorder (MDD), adults Project Number SR0621-000 Call for patient input 2019-05-27 ...

Pharmaceutical Reviews Update 8

May 23, 2019
See Pharmaceutical Reviews Update – Issue 8 for important news and information regarding CADTH’s drug review programs. Highlights from this issue include: details around when patient groups may be re-engaged in the CADTH Common Drug Review (CDR) process following an initial call for patient input an announcement on a...

Call for Patient Input and Clinical Experts: Vascepa

May 17, 2019
CADTH has received the following notice(s) of pending drug submission(s). Brand name Vascepa Generic name icosapent ethyl Manufacturer HLS Therapeutics Indication(s) Ischemic events in statin-treated patients Project Number SR0619-000 Call for patient input 2019-05-17 ...

New at CADTH - May 2019

May 7, 2019
Read this month’s issue of New at CADTH. Here, you’ll find the latest information on our products and services, corporate news, and news flashes of upcoming events across Canada.

Calls for Patient Input: Benlysta, Onstryv and Takhzyro

April 30, 2019
CADTH has received the following notice(s) of pending drug submission(s). Brand name Benlysta Generic name belimumab Manufacturer GlaxoSmithKline Inc. Indication(s) Systemic lupus erythematosus Project Number SR0616-000 Call for patient input 2019-04-30 Patient inp...